Imagine this: You're one of the more than 5.1 million Americans who have heart failure. And that means a trip to the hospital, a lower quality of life and an increased risk of death.
Now consider this scenario: You see a doctor who non-surgically implants a wireless mini-device (known as The CardioMEMS system) into your heart. That system monitors pulmonary artery pressure and transmits those readings every day to your doctor. Then, your doctor sees an increase in that pressure (this often happens before weight and blood pressure changes, which are often used as indirect measures of worsening heart failure) and contacts you to devise a plan.
For some patients at HonorHealth John C. Lincoln Medical Center, this scenario is becoming a reality. The CardioMEMS System is an FDA-approved heart failure monitoring device that has been proven to significantly reduce hospital admissions when used by physicians to manage heart failure. The sensor is designed to last your whole life and doesn't even require batteries. You won't even feel it when it's conducting readings.
"We're already seeing reduced hospital readmissions due to heart failure among patients who have CardioMEMS," said Mark Seifert, MD. "This is a benefit to the patient, community and the hospital – heart failure costs the nation an estimated $32 billion per year."
Jill Berger, a 66-year-old Peoria resident, has been hospitalized three times in the past year due to heart failure. "I'm feeling great, and have great peace of mind about my health with this system in place," she said.
Data from a clinical trial showed that the CardioMEMS technology reduces heart failure hospital admissions by up to 37 percent. The CHAMPION trial studied the effectiveness of the CardioMEMS HF System in New York Heart Association (NYHA) Functional Classification System class III heart failure patients who had been hospitalized for heart failure in the previous 12 months.